BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30132507)

  • 1. Serum miR-30d as a novel biomarker for multiple myeloma and its antitumor role in U266 cells through the targeting of the MTDH/PI3K/Akt signaling pathway.
    Zhu B; Chen H; Zhang X; Pan Y; Jing R; Shen L; Wang X; Ju S; Jin C; Cong H
    Int J Oncol; 2018 Nov; 53(5):2131-2144. PubMed ID: 30132507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway.
    Liu S; Zhang Y; Huang C; Lin S
    J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-30d induces apoptosis and is regulated by the Akt/FOXO pathway in renal cell carcinoma.
    Wu C; Jin B; Chen L; Zhuo D; Zhang Z; Gong K; Mao Z
    Cell Signal; 2013 May; 25(5):1212-21. PubMed ID: 23416459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
    Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
    Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of microRNA‑25‑3p inhibits the proliferation and promotes the apoptosis of multiple myeloma cells via targeting the PTEN/PI3K/AKT signaling pathway.
    Zi Y; Zhang Y; Wu Y; Zhang L; Yang R; Huang Y
    Int J Mol Med; 2021 Mar; 47(3):. PubMed ID: 33448321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
    Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
    Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-202 inhibits cell proliferation, migration and invasion of glioma by directly targeting metadherin.
    Yang J; Fan B; Zhao Y; Fang J
    Oncol Rep; 2017 Sep; 38(3):1670-1678. PubMed ID: 28714009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway.
    Gao J; Zhou XL; Kong RN; Ji LM; He LL; Zhao DB
    Exp Mol Pathol; 2016 Feb; 100(1):192-8. PubMed ID: 26723864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA OIP5-AS1 loss-induced microRNA-410 accumulation regulates cell proliferation and apoptosis by targeting KLF10 via activating PTEN/PI3K/AKT pathway in multiple myeloma.
    Yang N; Chen J; Zhang H; Wang X; Yao H; Peng Y; Zhang W
    Cell Death Dis; 2017 Aug; 8(8):e2975. PubMed ID: 28796257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway.
    Li J; Ye D; Shen P; Liu X; Zhou P; Zhu G; Xu Y; Fu Y; Li X; Sun J; Xu J; Zhang Q
    J Exp Clin Cancer Res; 2020 Oct; 39(1):212. PubMed ID: 33032635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-197 inhibits gastric cancer progression by directly targeting metadherin.
    Liao Z; Li Y; Zhou Y; Huang Q; Dong J
    Mol Med Rep; 2018 Jan; 17(1):602-611. PubMed ID: 29115517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW; Wang SH; Wei X; Hou YZ; Li ZH
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of microRNA‑182 inhibits cell viability, invasion and angiogenesis in retinoblastoma through inhibition of the PI3K/AKT pathway and CADM2 upregulation.
    Huang YX; Nie XG; Li GD; Fan DS; Song LL; Zhang XL
    Int J Oncol; 2018 Dec; 53(6):2615-2626. PubMed ID: 30320366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-30d suppresses proliferation and invasiveness of pancreatic cancer by targeting the SOX4/PI3K-AKT axis and predicts poor outcome.
    Xu X; Zong K; Wang X; Dou D; Lv P; Zhang Z; Li H
    Cell Death Dis; 2021 Apr; 12(4):350. PubMed ID: 33824274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-301a promotes cell proliferation by directly targeting TIMP2 in multiple myeloma.
    Liang B; Yin JJ; Zhan XR
    Int J Clin Exp Pathol; 2015; 8(8):9168-74. PubMed ID: 26464662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.